Pharmaceutical Technology

JUNE 21, 2023

CSL announced the first patient with haemophilia B has been treated with its recently approved gene therapy Hemgenix (etranacogene dezaparvovec). Hemgenix is the first and only gene therapy approved for haemophilia B. This followed positive results from CSL’s Phase III HOPE-B trial (NCT03569891).

Patients 98

Patients Food and Drug Administration Engineering Sales 98

European Pharmaceutical Review

DECEMBER 27, 2023

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. 1 Following in vitro production from T cells collected from a patient’s leukapheresis procedure, the CAR T cells are infused back into the patient’s blood, where they proliferate and expand. This is variable and to some extent unpredictable.

Manufacturing 85

Manufacturing Food and Drug Administration Patients Pharma 85

European Pharmaceutical Review

NOVEMBER 10, 2022

Advanced light microscopy techniques have emerged as a foundation of biomedical research, capable of visualising cellular functions at very high resolution whilst being minimally invasive to the cells or tissues of interest. Dr Lorna Fitzpatrick is Lead Scientist – Cell and Molecular Engineering, Medicines Discovery Catapult.

Medicine 97

Medicine Distribution Engineering Electronics 97

Evolve Your Success

JUNE 13, 2023

We’re looking at skin cancer like melanoma and squamous cell carcinoma. We take a look at the tumor biology of that. These patients are already diagnosed with invasive melanoma or high-risk squamous cell carcinoma. He talked about how cancer is a cell that’s not acting the way it should. They just want the name tag.

Sales 52

Sales Medical sales Medical Doctors 52